REPL
Price
$4.35
Change
-$0.21 (-4.61%)
Updated
Oct 14 closing price
Capitalization
339.54M
34 days until earnings call
Intraday Buy/Sell Signals
SPRY
Price
$10.66
Change
-$0.27 (-2.47%)
Updated
Oct 14 closing price
Capitalization
1.05B
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

REPL vs SPRY

Header iconREPL vs SPRY Comparison
Open Charts REPL vs SPRYBanner chart's image
Replimune Group
Price$4.35
Change-$0.21 (-4.61%)
Volume$3.74M
Capitalization339.54M
ARS Pharmaceuticals
Price$10.66
Change-$0.27 (-2.47%)
Volume$1.66M
Capitalization1.05B
REPL vs SPRY Comparison Chart in %
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REPL vs. SPRY commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REPL is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (REPL: $4.35 vs. SPRY: $10.66)
Brand notoriety: REPL and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REPL: 104% vs. SPRY: 57%
Market capitalization -- REPL: $339.54M vs. SPRY: $1.05B
REPL [@Biotechnology] is valued at $339.54M. SPRY’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REPL’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • REPL’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, REPL is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REPL’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • REPL’s TA Score: 6 bullish, 2 bearish.
  • SPRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, REPL is a better buy in the short-term than SPRY.

Price Growth

REPL (@Biotechnology) experienced а -6.45% price change this week, while SPRY (@Biotechnology) price change was +3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

REPL is expected to report earnings on Nov 18, 2025.

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.05B) has a higher market cap than REPL($340M). SPRY YTD gains are higher at: 1.043 vs. REPL (-64.079). SPRY has higher annual earnings (EBITDA): -59.34M vs. REPL (-268.18M). REPL has more cash in the bank: 403M vs. SPRY (240M). SPRY has less debt than REPL: SPRY (1.66M) vs REPL (76.3M). SPRY has higher revenues than REPL: SPRY (112M) vs REPL (0).
REPLSPRYREPL / SPRY
Capitalization340M1.05B32%
EBITDA-268.18M-59.34M452%
Gain YTD-64.0791.043-6,146%
P/E RatioN/A152.50-
Revenue0112M-
Total Cash403M240M168%
Total Debt76.3M1.66M4,594%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REPLSPRY
RSI
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 8 days ago
80%
Momentum
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
85%
MACD
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
86%
Bullish Trend 8 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
74%
Bearish Trend 8 days ago
89%
Aroon
ODDS (%)
Bullish Trend 8 days ago
80%
Bearish Trend 8 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVTAX11.270.08
+0.71%
SEI Global Managed Volatility F (SIMT)
LAVTX17.170.11
+0.64%
Lord Abbett Fundamental Equity R5
JHAAX10.650.05
+0.47%
JHancock Multi-Asset Absolute Return A
FULVX11.94N/A
N/A
Fidelity U.S. Low Volatility Equity
HSWFX21.88-0.03
-0.14%
Hartford Schroders International Stk F

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-4.61%
IMNN - REPL
56%
Loosely correlated
+1.59%
SNDX - REPL
49%
Loosely correlated
+0.72%
KYMR - REPL
46%
Loosely correlated
-2.72%
ERAS - REPL
44%
Loosely correlated
+0.42%
BEAM - REPL
43%
Loosely correlated
+0.12%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with ANAB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then ANAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-2.47%
ANAB - SPRY
36%
Loosely correlated
-1.88%
KROS - SPRY
33%
Loosely correlated
-5.03%
REPL - SPRY
31%
Poorly correlated
-4.61%
SMMT - SPRY
29%
Poorly correlated
-5.15%
NUVL - SPRY
29%
Poorly correlated
-5.67%
More